Sort
15,273 grants matching “antimicrobial resistance”
Intrinsic modifiers of beta-lactam resistance in nosocomial Enterobacterales
$199,348Jacob Eric Lazarus · Massachusetts General Hospital · K08 · FY2021 · AI
Non-Self Recognition and Immune Suppression in Drosophila
$199,303Shubha Govind · City College Of New York · S06 · FY2010 · GM
A mobile health tool to improve antibiotic stewardship among village doctors in Bangladesh
$199,290Daniel Ted Leung · Utah State Higher Education System--University Of Utah · R33 · FY2025 · HD
Intrinsic modifiers of beta-lactam resistance in nosocomial Enterobacterales
$199,277Jacob Eric Lazarus · Massachusetts General Hospital · K08 · FY2022 · AI
Novel Indigoid Anti-Tuberculosis Agents
$199,115Larry Klein · University Of Illinois At Chicago · R21 · FY2012 · AI
Bacteriophage as a predictive biomarker in chronic Pseudomonas airway disease
$199,044Elizabeth Bendig Burgener · Children'S Hospital Of Los Angeles · K23 · FY2024 · HL
Bacteriophage as a predictive biomarker in chronic Pseudomonas airway disease
$199,044Elizabeth Bendig Burgener · Children'S Hospital Of Los Angeles · K23 · FY2025 · HL
Bacteriophage as a predictive biomarker in chronic Pseudomonas airway disease
$199,044Elizabeth Bendig Burgener · Children'S Hospital Of Los Angeles · K23 · FY2023 · HL
Functional Characterization of Prostaglandin D2 in Chronic Spontaneous Urticaria
$198,965Eric T Oliver · Johns Hopkins University · K23 · FY2020 · AI
Development of HAMLET as a Adjuvant for the Treatment of Drug-resistant Staphylococcus Aureus Infections
$198,948Katie J. Edwards · Cubrc, Inc. · R21 · FY2017 · AI
Development of HAMLET as a Adjuvant for the Treatment of Drug-resistant Staphylococcus Aureus Infections
$198,948Katie J. Edwards · Cubrc, Inc. · R21 · FY2016 · AI
Population Genomics of Staphylococci
$198,835Ashley Robinson · University Of Mississippi Med Ctr · R01 · FY2016 · GM
Population Genomics of Staphylococci
$198,835Ashley Robinson · University Of Mississippi Med Ctr · R01 · FY2015 · GM
Parasite Drug Susceptibility in The Response To Anti-Leishmanial Treatment
$198,783Nancy Gore Saravia · Centro Internacional (Cideim) · U19 · FY2021 · AI
Antimicrobial Use Data Collection in the U.S. Poultry Production System
$198,770Randall S Singer · Mindwalk Consulting Group, Llc · U01 · FY2025 · FD
Antimicrobial Use Data Collection in the U.S. Poultry Production System
$198,770Randall S Singer · Mindwalk Consulting Group, Llc · U01 · FY2024 · FD
Profiling the Lung Transcriptome for Precision Diagnosis of Respiratory Infections using Host/Pathogen Metagenomic Sequencing
$198,760Charles Langelier · University Of California, San Francisco · K23 · FY2019 · HL
Synthetic lethality of bicyclomycin
$198,750Karl A Drlica · Rbhs-New Jersey Medical School · R21 · FY2014 · AI
Manganese acquisition and Mycobacterium tuberculosis virulence
$198,750Gloria Marcela Rodriguez · Rbhs-New Jersey Medical School · R21 · FY2017 · AI
Host-derived biomarker signatures to differentiate acute viral, bacterial, and fungal infection
$198,750Micah T. McClain · Duke University · R21 · FY2017 · AI
Disappearance of rifampin resistance in MRSA foreign body osteomyelitis
$198,750Robin Patel · Mayo Clinic Rochester · R21 · FY2016 · AI
Genomic variation in epidemic carbapenem-resistant K.pneumoniae
$198,750Liang Chen · Rbhs-New Jersey Medical School · R21 · FY2017 · AI
Defining novel mechanisms of clonal emergence in Group A Streptococcus
$198,750Samuel A Shelburne · University Of Tx Md Anderson Can Ctr · R21 · FY2022 · AI
Ureaplasma urealyticum- and Ureaplasma parvum-associated hyperammonemia
$198,750Robin Patel · Mayo Clinic Rochester · R21 · FY2020 · AI
Molecular triggers of persistent Mycobacterium abscessus infections
$198,750Nancy Ann Woychik · Rbhs-Robert Wood Johnson Medical School · R21 · FY2019 · AI